There are an estimated 28 million vapers worldwide in 2017 more than double the number there were in 2015, and the opportunity to attract the estimated 860 million smokers worldwide with Electronic Vapour Products (EVPs) is still largely unexplored. Vaping is already a much larger market than nicotine replacement therapies like gums and patches – and is forecast to surpass $15 billion by 2019.
The growth of vaping has been a truly consumer-led revolution. The staggering growth in sales of EVPs shows they meet a range of social and lifestyle needs. There is also a growing consensus that they may also contribute to significant public health benefits, as supported by an increasingly large number of public health professionals, including Public Health England and Belgium’s Superior Health Council. EVPs are, for the vast majority of users, a new alternative for some or all of the tobacco products they use.
At Fontem we believe that vaping is the future, and we can continue to innovate new products that provide more choice to consumers while also focusing on the quality and safety our customers demand and deserve.